Adherence to deferoxamine therapy: Heeding Hippocrates and Osler-Reference-Cited by-同舟云学术

Adherence to deferoxamine therapy: Heeding Hippocrates and Osler

Published:2004 Issue:4 Volume:76 Page:415-416
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Olivieri Nancy F.

Publisher

Wiley

Subject

Hematology

Reference20 articles.

1. Iron-Chelating Therapy and the Treatment of Thalassemia

2. Comparison of subcutaneous infusion needles for transfusion dependent thalassemia patients by intra-personal crossover assessment model. Am J Hematol 2004 (this issue).

3. Survival in Medically Treated Patients with Homozygous β-Thalassemia

4. Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major

5. Survival and Disease Complications in Thalassemia Major

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular genetics of RASopathies : An update on novel disease genes and new disorders;American Journal of Medical Genetics Part C: Seminars in Medical Genetics;2022-11-16

2. Regular Reminding of the Potential Serious Complications of Poor Adherence to Treatment: A Strategy for Improving Treatment Adherence in Beta-Thalassemia Major Patients;INT J PEDIATR-MASSHA;2017

3. Implementation of Evidence-Based Care in Pediatric Hematology/Oncology Practice;Patient Safety and Quality in Pediatric Hematology/Oncology and Stem Cell Transplantation;2017

4. Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial;American Journal of Hematology;2015-05-03

5. Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis;Current Cancer Drug Targets;2014-08-31